Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.
Pfizer Raises 2022 Earnings Guidance
Description
Phizer ($PFE@US) raised its 2022 earnings guidance for 2022 after a strong third quarter. The pharmaceutical company adjusted its earnings per share to $1.78 from the $1.39 expected and revenues to $22.6 billion from the $21 billion expected. The strong sales are attributed to COVID vaccines, the antiviral treatment Paxlovid, and the blood thinner Eliquis. Phizer CEO Albert Bourla said the company is looking beyond COVID and is testing an RSV vaccine for mothers in their second or third trimester of pregnancy.
Keywords & Tags
#earnings
#business
#earnings season
#pharmaceutical company
#analysts
#big pharma
#beat estimates
#profit
#Q3
#pharmacy
#analyst estimates
#annual report
#quarterly report
#Strong Sales
#COVID Vaccines
#Phizer increases 2022 earnings guidance
#Paxlovid
#blood thinner
#Eliquis
#CEO Albert Bourla
#RSV vaccine
More from User
00:51
Trump Limits GPT-5.6 Rollout
Benzinga
00:52
Bayer Wins Roundup Case
Benzinga
00:50
Micron’s $22B AI Bet
Benzinga
01:00
Take4
Benzinga
00:53
Meta Memoir Lawsuit
Benzinga
03:17
Stock Market Today: Dow Jones Inches Up, S&P 500 And Nasdaq Futures Slip As Tech Selloff Gathers Pace
Benzinga
Related Videos
03:34
Adobe Shares Sink After The Company Reported Q4 Earnings And Issued Q1 And FY24 Total Revenue Guidance Below Estimates
Benzinga
00:40
Goldman Sachs Beats Analyst Estimates with Q3 Earnings Estimates
Benzinga
08:33
Palantir Q2 Earnings: Revenue, EPS Beat Estimates, Company Raises Guidance Citing 'Astonishing Impact' Of AI Leverage
Benzinga
00:39
Broadcom Exceeds Q1 Earnings Estimates, Driven by AI Boom and Strong Guidance
Benzinga
04:14
Qualcomm Q4 Earnings Highlights: Revenue Beat, EPS Beat, Chipmaker's Guidance Comes In Ahead Of Estimates
Benzinga
00:29
Adobe Beats Q3 Earnings and Revenue Estimates, Driven by Creative Cloud and Firefly AI. Stock Slides on Weak Q4 Guidance.
Benzinga